Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This hybrid event at St Luke's Chapel, Oxford and online, explores the remarkable national expansion of opt-out HIV, hepatitis B and hepatitis C testing in NHS Accident & Emergency departments, from an initial pilot in 10 hospitals to 87 sites across England. Drawing on the journey from early implementation to large-scale adoption, Ian will examine how robust evidence, effective commissioning and collaboration across the health system have transformed an innovative pilot into a nationally recognised programme.

Beyond the story of scale-up, the lecture, chaired by Bakita Kasadha, NIHR Doctoral Research Fellow in the Department, will consider the wider lessons for public health and healthcare delivery. It will explore how implementation science, surveillance data, clinician behaviour and health economic evidence combined to demonstrate both clinical impact and cost-effectiveness, helping to shape national policy and investment. 

The expansion of opt-out testing has significant implications for reducing health inequalities, improving earlier diagnosis and ensuring equitable access to care for populations who may otherwise remain undiagnosed. At this lecture Ian will offer valuable insights for researchers, clinicians, educators, commissioners and policymakers interested in translating evidence into practice and delivering meaningful improvements in population health.